| Literature DB >> 34657588 |
Xuezhi Wang1, Dongzi Lin1, Zengqi Huang1, Jinmei Zhang1, Wenyan Xie2, Pen Liu2, Huaiqi Jing3, Jiazheng Wang4.
Abstract
BACKGROUND: Bloodstream infection (BSI) caused by Staphylococcus aureus (S. aureus) can be life-threatening and pose a great challenge to infection control and clinical treatment. However, little information exists regarding the characterization of S. aureus in BSI patients in Shandong, China. To identify the clonality, virulence genes, and antibiotic resistance of S. aureus in blood, a total of 101 nonrepetitive blood isolates were collected. The antibiotic resistance phenotypes were determined, and virulence genes were analyzed with polymerase chain reaction (PCR). Finally, the genetic relatedness was investigated with Staphylococcus chromosomal cassette mec (SCCmec) typing for methicillin-resistant S. aureus (MRSA) isolates, Staphylococcal protein A (spa), and multilocus sequence typing (MLST) for all of 101 isolates.Entities:
Keywords: Antibiotic resistance; Blood; Molecular characterization; Staphylococcus aureus; Virulence genes
Mesh:
Substances:
Year: 2021 PMID: 34657588 PMCID: PMC8522240 DOI: 10.1186/s12866-021-02344-6
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Resistance rates of S. aureus isolates obtained from blood
| Antimicrobial | Resistance rate (%) | |||
|---|---|---|---|---|
| Overall | MRSA | MSSA | ||
| ( | ( | ( | ||
| Penicillin | 86(85.1) | 24(100) | 62(80.5) | 0.044 |
| Cefoxitin | 24(23.8) | 24(100) | 0(0) | 0.000 |
| Oxacillin | 24(23.8) | 24(100) | 0(0) | 0.000 |
| Gentamicin | 15(14.9) | 5(20.8) | 10(13.0) | 0.538 |
| Ciprofloxacin | 21(20.8) | 8(33.3) | 13(16.9) | 0.148 |
| Levofloxacin | 21(20.8) | 8(33.3) | 13(16.9) | 0.148 |
| Moxifloxacin | 17(16.8) | 7(29.2) | 10(13.0) | 0.124 |
| Erythromycin | 82(81.2) | 23(95.8) | 59(76.6) | 0.071 |
| Clindamycin | 79(78.2) | 22(91.7) | 57(74.0) | 0.068 |
| Linezolid | 0(0) | 0(0) | 0(0) | – |
| Vancomycin | 0(0) | 0(0) | 0(0) | – |
| Tetracycline | 23(22.8) | 14(58.3) | 9(11.7) | 0.000 |
| Tigecycline | 0(0) | 0(0) | 0(0) | – |
| Rifampicin | 3(3.0) | 3(12.5) | 0(0) | 0.014 |
| Trimethoprim/Sulfamethoxazole | 22(21.8) | 2(8.3) | 20(26.0) | 0.068 |
| MDR | 77(76.2) | 23(95.8) | 54(70.1) | 0.010 |
Prevalence of virulence genes of S. aureus isolates obtained from blood
| gene | Total ( | distributing in | ||
|---|---|---|---|---|
| MRSA ( | MSSA ( | |||
| 2(2.0) | 0(0) | 2(2.6) | 1.000 | |
| 0(0) | 0(0) | 0(0) | – | |
| 14(13.9) | 6(25.0) | 8(10.4) | 0.141 | |
| 33(32.7) | 12(50.0) | 21(27.3) | 0.038 | |
| 13(12.9) | 3(12.5) | 10(13.0) | 1.000 | |
| 33(32.7) | 4(16.7) | 29(37.7) | 0.056 | |
| 2(2.0) | 0(0) | 2(2.6) | 1.000 | |
| 37(36.6) | 4(16.7) | 33(42.9) | 0.020 | |
| 2(2.0) | 0(0) | 2(2.6) | 1.000 | |
| 37(36.6) | 4(16.7) | 33(42.9) | 0.020 | |
| 33(32.7) | 5(20.8) | 28(36.4) | 0.157 | |
| 101(100) | 24(100) | 77(100) | – | |
| 37(36.6) | 17(70.8) | 20(26.0) | 0.000 | |
| 101(100) | 24(100) | 77(100) | – | |
| 101(100) | 24(100) | 77(100) | – | |
| 22(21.8) | 5(20.8) | 17(22.1) | 0.897 | |
| 5(5.0) | 3(12.5) | 2(2.6) | 0.157 | |
Fig. 1Phylogenetic and population structure analysis of isolates. A Minimum-spanning tree of 101 S. aureus isolates from blood based on MLST. Each ST is represented by a circle sized in proportion to the number of isolates represented by that ST. The gray shaded areas surrounding the STs denote types that belong to the same CC. The number of allelic differences between STs is indicated on the branches. MRSA isolates are represented by red color while MSSA isolates are represented by green color. The detailed MLST profiles can be seen in the Additional file 2. B The maximum likelihood tree of 101 S. aureus isolates for MLST typing. The maximum likelihood tree was constructed based on the seven combined housekeeping genes sequences. Bootstrap support was based on 1000 replicates, and only branch nodes higher than 60 were shown
Allelic profiles of the novel STs found in this study
| ST | |||||||
|---|---|---|---|---|---|---|---|
| ST6663 | 7 | 6 | 1 | 5 | 19 | 8 | 6 |
| ST6664 | 5 | 4 | 444 | 4 | 8 | 6 | 15 |
| ST6665 | 7 | 6 | 1 | 5 | 7 | 8 | 3 |
| ST6666 | 13 | 13 | 1 | 1 | 7 | 11 | 5 |
| ST6667 | 6 | 5 | 6 | 2 | 7 | 14 | 13 |
| ST6731 | 19 | 23 | 15 | 2 | 19 | 20 | 901 |
| ST6732 | 4 | 1 | 4 | 1 | 5 | 757 | 4 |
| ST6733 | 790 | 23 | 15 | 2 | 19 | 20 | 15 |
| ST6734 | 19 | 23 | 862 | 2 | 19 | 20 | 15 |
| ST6762 | 19 | 23 | 864 | 2 | 4 | 20 | 6 |
| ST6763 | 794 | 13 | 1 | 1 | 12 | 11 | 13 |
| ST6773 | 6 | 5 | 6 | 2 | 12 | 14 | 5 |
| ST6774 | 19 | 23 | 864 | 2 | 19 | 20 | 15 |
| ST6776 | 4 | 1 | 4 | 1 | 5 | 762 | 4 |
| ST6777 | 3 | 35 | 19 | 2 | 20 | 26 | 912 |
Molecular characteristics of S. aureus isolates collected in this study
| CC(no.) | MLST(no.) | MRSA(no.) | MSSA(no.) | SCC | |
|---|---|---|---|---|---|
| CC59(20) | ST59(16) | t437(12) | 10 | 2 | IVa(10) |
| t163(2) | 2 | ||||
| t1950(1) | 1 | ||||
| t441(1) | 1 | ||||
| ST6731(1) | t437(1) | 1 | IVa(1) | ||
| ST6733(1) | t437(1) | 1 | |||
| ST6734(1) | t172(1) | 1 | IVa(1) | ||
| ST6774(1) | t1751(1) | 1 | NT(1) | ||
| CC398(13) | ST398(12) | t571(9) | 1 | 8 | III(1) |
| t034(2) | 2 | ||||
| t7160(1) | 1 | ||||
| ST6777(1) | NT(1) | 1 | |||
| CC5(13) | ST5(11) | t002(4) | 4 | ||
| t954(2) | 2 | ||||
| t1084(1) | 1 | ||||
| t13506(1) | 1 | ||||
| t2460(1) | 1 | II(1) | |||
| t5076(1) | 1 | II(1) | |||
| t668(1) | 1 | ||||
| ST965(1) | t062(1) | 1 | |||
| ST5039(1) | t002(1) | 1 | |||
| CC22(10) | ST22(9) | t309(5) | 5 | ||
| t1516(1) | 1 | ||||
| t2336(1) | 1 | ||||
| t5335(1) | 1 | ||||
| t7611(1) | 1 | ||||
| ST6663(1) | t5335(1) | 1 | |||
| CC15(5) | ST15(4) | t084(4) | 4 | ||
| t14014(1) | 1 | ||||
| ST6763(1) | t084(1) | 1 | |||
| CC239(8) | ST239(4) | t030(3) | 3 | III(3) | |
| t037(1) | 1 | NT(1) | |||
| ST630(2) | t377(2) | 2 | |||
| ST8(2) | t008(1) | 1 | IVa(1) | ||
| t024(1) | 1 | ||||
| CC25(6) | ST25(4) | t349(1) | 1 | ||
| t078(1) | 1 | ||||
| t472(1) | 1 | ||||
| t078(1) | 1 | ||||
| ST6732(1) | t18446(1) | 1 | |||
| ST6776(1) | NT(1) | 1 | |||
| Singletons(25) | ST6(5) | t701(4) | 4 | ||
| t2467(1) | 1 | ||||
| ST188(4) | t189(4) | 4 | |||
| ST7(3) | t796(2) | 2 | |||
| t091(1) | 1 | ||||
| ST1(2) | t127(2) | 2 | |||
| ST72(1) | t324(1) | 1 | |||
| ST88(1) | t1764(1) | 1 | NT(1) | ||
| ST707(1) | t4523(1) | 1 | |||
| ST1777(1) | t318(1) | 1 | III(1) | ||
| ST3969(1) | t159(1) | 1 | |||
| ST6664(1) | t796(1) | 1 | |||
| ST6665(1) | t309(1) | 1 | |||
| ST6666(1) | t346(1) | 1 | |||
| ST6667(1) | t2091(1) | 1 | |||
| ST6762(1) | t1751(1) | 1 | NT(1) | ||
| ST6773(1) | t2092(1) | 1 |
Resistance rates among ST59-t437 and ST398-t571 isolates
| Antimicrobial | Resistance rate (%) | ||
|---|---|---|---|
| ST59-t437 | ST398-t571 | ||
| ( | ( | ||
| Penicillin | 12(100.0%) | 4(44.4%) | 0.006 |
| Cefoxitin | 10(83.3%) | 1(11.1%) | 0.002 |
| Oxacillin | 10(83.3%) | 1(11.1%) | 0.002 |
| Gentamicin | 0(0.0%) | 0(0.0%) | – |
| Ciprofloxacin | 1(8.3%) | 1(11.1%) | 1.000 |
| Levofloxacin | 1(8.3%) | 1(11.1%) | 1.000 |
| Moxifloxacin | 1(8.3%) | 1(11.1%) | 1.000 |
| Erythromycin | 12(100.0%) | 5(55.6%) | 0.021 |
| Clindamycin | 12(100.0%) | 5(55.6%) | 0.021 |
| Linezolid | 0(0.0%) | 0(0.0%) | – |
| Vancomycin | 0(0.0%) | 0(0.0%) | – |
| Tetracycline | 7(58.3%) | 0(0.0%) | 0.007 |
| Tigecycline | 0(0.0%) | 0(0.0%) | – |
| Rifampicin | 0(0.0%) | 0(0.0%) | – |
| Trimethoprim/Sulfamethoxazole | 0(0.0%) | 2(22.2%) | 0.171 |
Prevalence of virulence genes among ST59-t437 and ST398-t571 isolates
| gene | distributing in | ||
|---|---|---|---|
| ST59-t437 ( | ST398-t571 ( | ||
| 1(8.3) | 0(0) | 1.000 | |
| 0(0) | 0(0) | – | |
| 0(0) | 1(11.1) | 0.429 | |
| 8(66.7) | 0(0) | 0.005 | |
| 1(8.3) | 0(0) | 1.000 | |
| 5(41.7) | 3(33.3) | 1.000 | |
| 0(0) | 0(0) | – | |
| 3(25.0) | 0(0) | 0.229 | |
| 0(0) | 0(0) | – | |
| 3(25.0) | 0(0) | 0.229 | |
| 4(33.3) | 3(33.3) | 1.000 | |
| 12(100) | 9(100) | – | |
| 12(100) | 1(11.1) | 0.000 | |
| 12(100) | 9(100) | – | |
| 12(100) | 9(100) | – | |
| 2(16.7) | 1(11.1) | 1.000 | |
| 0(0) | 0(0) | – | |